Literature DB >> 17786052

Role of beta-catenin in adult cardiac remodeling.

Laura Zelarayan1, Christina Gehrke, Martin W Bergmann.   

Abstract

The adult heart has a uniform cellular response to adapt to injury after infarct or increased wall stress in chronic hypertension: hypertrophy of adult cardiomyocytes increases muscle fiber mass while at the same time apoptosis of cardiomyocytes may lead to further loss of contractile mass. The existence and quantitative amount of endogenous cardiac regeneration is currently under intense dispute, no clear picture has yet emerged. Recently, cardiac precursor cells and the signaling pathways controlling their differentiation in the adult organ have come into focus. In heart development, beta-catenin was identified to play a biphasic role in cardiomyocyte differentiation. While initially WNT/beta-catenin activation is required to commit mesenchymal cells to the cardiac lineage, downregulation of beta-catenin is needed for cardiomyocyte differentiation at later stages. Recent genetic data published by our lab suggest beta-catenin downregulation to be beneficial for adult cardiac remodeling. Here we discuss these data in the context of beta-catenin's role in adult cardiomyocyte hypertrophy, apoptosis and possibly regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786052     DOI: 10.4161/cc.6.17.4632

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies.

Authors:  Nathan J Palpant; Fikru B Bedada; Brandon Peacock; Bruce R Blazar; Joseph M Metzger; Jakub Tolar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

2.  Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy.

Authors:  Piotr Sklepkiewicz; Takayuki Shiomi; Rajbir Kaur; Jie Sun; Susan Kwon; Becky Mercer; Peter Bodine; Ralph Theo Schermuly; Isaac George; P Christian Schulze; Jeanine M D'Armiento
Journal:  Circ Heart Fail       Date:  2015-02-10       Impact factor: 8.790

3.  Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats.

Authors:  Jing-Jing Liu; Lu-Mei Shentu; Ning Ma; Li-Ying Wang; Gui-Min Zhang; Ying Sun; Yan Wang; Jun Li; Yan-Ling Mu
Journal:  Curr Med Sci       Date:  2020-03-13

Review 4.  Wnt signaling, a novel pathway regulating blood pressure? State of the art review.

Authors:  Maen D Abou Ziki; Arya Mani
Journal:  Atherosclerosis       Date:  2017-05-04       Impact factor: 5.162

Review 5.  Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury.

Authors:  Arjun Deb
Journal:  Cardiovasc Res       Date:  2014-03-03       Impact factor: 10.787

6.  MicroRNA expression, target genes, and signaling pathways in infants with a ventricular septal defect.

Authors:  Hui Chai; Zhaoyuan Yan; Ke Huang; Yuanqing Jiang; Lin Zhang
Journal:  Mol Cell Biochem       Date:  2017-08-18       Impact factor: 3.396

7.  Myozap Deficiency Promotes Adverse Cardiac Remodeling via Differential Regulation of Mitogen-activated Protein Kinase/Serum-response Factor and β-Catenin/GSK-3β Protein Signaling.

Authors:  Ashraf Yusuf Rangrez; Matthias Eden; Reza Poyanmehr; Christian Kuhn; Katharina Stiebeling; Franziska Dierck; Alexander Bernt; Renate Lüllmann-Rauch; Hartmut Weiler; Paulus Kirchof; Derk Frank; Norbert Frey
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

8.  Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways.

Authors:  Jeffrey Schmeckpeper; Amanda Verma; Lucy Yin; Farideh Beigi; Lunan Zhang; Alan Payne; Zhiping Zhang; Richard E Pratt; Victor J Dzau; Maria Mirotsou
Journal:  J Mol Cell Cardiol       Date:  2015-06-10       Impact factor: 5.000

Review 9.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

10.  Inhibiting the Pkm2/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI.

Authors:  Ludger Hauck; Keith Dadson; Shelly Chauhan; Daniela Grothe; Filio Billia
Journal:  Cell Death Differ       Date:  2020-12-07       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.